284 related articles for article (PubMed ID: 26564994)
1. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Yamasaki R; Matsushita T; Fukazawa T; Yokoyama K; Fujihara K; Ogino M; Yokota T; Miyamoto K; Niino M; Nomura K; Tomioka R; Tanaka M; Kawachi I; Ohashi T; Kaida K; Matsui M; Nakatsuji Y; Ochi H; Fukaura H; Kanda T; Nagaishi A; Togo K; Mizusawa H; Murai H; Kira J
Mult Scler; 2016 Sep; 22(10):1337-48. PubMed ID: 26564994
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica.
Guo S; Jiang H; Jiang L; Peng J; Liu H; Wang J; Wei W
Sci Rep; 2021 Nov; 11(1):22229. PubMed ID: 34782653
[TBL] [Abstract][Full Text] [Related]
4. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R
Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Analysis of DTI Data to Assess Vision Outcome After Intravenous Methylprednisolone Therapy in Neuromyelitis Optic Neuritis.
Tian Y; Liu Z; Tang Z; Li M; Lou X; Dong E; Liu G; Wang Y; Wang Y; Bian X; Wei S; Tian J; Ma L
J Magn Reson Imaging; 2019 May; 49(5):1365-1373. PubMed ID: 30252996
[TBL] [Abstract][Full Text] [Related]
6. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica].
Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684
[No Abstract] [Full Text] [Related]
7. [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica].
Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):509-513. PubMed ID: 32842332
[No Abstract] [Full Text] [Related]
8. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
Songthammawat T; Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
Mult Scler Relat Disord; 2020 Feb; 38():101506. PubMed ID: 31731214
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
[TBL] [Abstract][Full Text] [Related]
10. [Short-term high-dose intravenous methylprednisolone therapy].
Ohashi T
Nihon Rinsho; 2014 Nov; 72(11):1995-8. PubMed ID: 25518383
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.
Nechemia Y; Moreh E; Weingarden H; Bloch A; Givon U; Vaknin-Dembinsky A; Schwartz I; Meiner Z; Zeilig G
J Spinal Cord Med; 2016 May; 39(3):311-6. PubMed ID: 26446695
[TBL] [Abstract][Full Text] [Related]
12. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
Warabi Y; Yagi K; Hayashi H; Matsumoto Y
J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
[TBL] [Abstract][Full Text] [Related]
14. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
[TBL] [Abstract][Full Text] [Related]
15. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders.
Lim YM; Kim H; Lee EJ; Kim HW; Kim HJ; Kim KK
Mult Scler Relat Disord; 2020 Jul; 42():102109. PubMed ID: 32387973
[TBL] [Abstract][Full Text] [Related]
18. Experience of Using Adrenocorticotropic Hormone in the Treatment of Patients With Acute Neuromyelitis Optica Who Failed Systemic Steroids: A Case Series.
Berkovich R
Clin Neuropharmacol; 2020; 43(1):7-14. PubMed ID: 31876792
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders.
Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
Mult Scler Relat Disord; 2018 Feb; 20():115-121. PubMed ID: 29414283
[TBL] [Abstract][Full Text] [Related]
20. Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
Li R; Wang J; Li C; Liu X; Chu M; Chang Y; Wang Y; Wang X; Yu B; Ling L; Yang H; Yang H; Hu X; Qiu W
J Neuroimmunol; 2021 Jul; 356():577604. PubMed ID: 33992860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
